As reported, high GFPT2 expression is associated with poor prognosis in various tumors, including gastric cancer, lung adenocarcinoma and colorectal cancer (Ding et al., 2022; Yang et al., 2023; Zhang et al., 2018). This evidence concerns the gene GFPT2 and lung adenocarcinoma.